Start Lipo B first if you want to optimise baseline mitochondrial function before introducing appetite suppression
health system continues to fail Americans by not viewing obesity as a disease, by not prioritizing anti-obesity treatments with all their attendant clinical benefits, and, above all, by not forcing both commercial and federal insurance plans to cover these treatments in a much more inclusive manner
Shed is a cash-pay platform only
Side effects are rare and generally mild
Our physicians evaluate patients for GLP-1 receptor agonist therapy and can prescribe these medications when medically appropriate
Trial registration Similar content being viewed by others Introduction Metabolic syndrome (MetS) is defined as a cluster of cardiovascular risk factors (i.e., abdominal obesity, hyperinsulinaemia, atherogenic dyslipidemia, hypertension, hypercogauability) that increase the risk of developing co-existing coronary heart disease (CHD) and type 2 diabetes [1]